EYEG KIORA PHARMACEUTICALS INC
- 36.105
- +0.150+0.42%
8-K: Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies
10-Q: Q2 2024 Earnings Report
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Officer Strem Brian M.
4: Statement of changes in beneficial ownership of securities-Officer Tosca Melissa
3: Initial statement of beneficial ownership of securities-Director Walters-Hoffert Lisa
4: Statement of changes in beneficial ownership of securities-Officer Daniels Eric Joseph
4: Statement of changes in beneficial ownership of securities-Director Stengone Carmine N.
4: Statement of changes in beneficial ownership of securities-Director Parsons Erin
4: Statement of changes in beneficial ownership of securities-Director Shapiro Aron
4: Statement of changes in beneficial ownership of securities-Director Walters-Hoffert Lisa
4: Statement of changes in beneficial ownership of securities-Director Hollander David
4: Statement of changes in beneficial ownership of securities-Director TYLE PRAVEEN
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Officer Tosca Melissa
4: Statement of changes in beneficial ownership of securities-Officer Daniels Eric Joseph
4: Statement of changes in beneficial ownership of securities-Director Parsons Erin
4: Statement of changes in beneficial ownership of securities-Officer Strem Brian M.
8-K: Current report
SC 13G: Statement of acquisition of beneficial ownership by individuals-Rosalind Advisors, Inc.(9.9%),Steven Salamon(9.9%), etc.